CXCR4 chemokine receptor signaling mediates pain in diabetic neuropathy

BACKGROUND: Painful Diabetic Neuropathy (PDN) is a debilitating syndrome present in a quarter of diabetic patients that has a substantial impact on their quality of life. Despite this significant prevalence and impact, current therapies for PDN are only partially effective. Moreover, the cellular me...

Descripción completa

Detalles Bibliográficos
Autores principales: Menichella, Daniela Maria, Abdelhak, Belmadani, Ren, Dongjun, Shum, Andrew, Frietag, Caroline, Miller, Richard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078021/
https://www.ncbi.nlm.nih.gov/pubmed/24961298
http://dx.doi.org/10.1186/1744-8069-10-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078021/
https://www.ncbi.nlm.nih.gov/pubmed/24961298
http://dx.doi.org/10.1186/1744-8069-10-42

Ejemplares similares